Goldmoney Inc. (TSX:XAU)

Sage Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	109	105	111	137	148	235
Market Cap Growth	-4.98%	-4.98%	-19.40%	-7.02%	-37.19%	6.93%
Enterprise Value	182	180	137	99	117	207
Last Close Price	8.62	7.98	8.38	9.80	9.75	15.55
PE Ratio	7.98	7.21	-	20.16	-	20.16
PS Ratio	1.04	1.01	1.62	1.58	0.41	0.35
PB Ratio	0.67	0.65	0.78	0.80	0.84	1.30
P/TBV Ratio	0.74	0.72	0.89	0.96	1.09	1.86
P/FCF Ratio	2.18	2.11	1.50	6.54	-	632.09
P/OCF Ratio	2.18	2.11	1.50	6.54	-	570.41
EV/Sales Ratio	1.75	1.72	2.01	1.14	0.33	0.31
EV/EBITDA Ratio	8.76	6.24	31.77	5.12	14.33	33.97
EV/EBIT Ratio	9.09	6.41	38.63	5.44	16.11	39.49
EV/FCF Ratio	3.67	3.61	1.87	4.70	-	556.88
Debt / Equity Ratio	0.53	0.53	0.28	-	0	0.02
Debt / EBITDA Ratio	3.01	3.01	8.99	-	0.00	0.62
Debt / FCF Ratio	1.74	1.74	0.53	-	-	10.46
Asset Turnover	0.36	0.36	0.33	0.49	1.96	3.54
Inventory Turnover	19.78	19.78	2.08	1.13	7.26	23.30
Quick Ratio	0.15	0.15	0.22	11.28	17.13	3.62
Current Ratio	1.08	1.08	1.14	28.17	49.66	11.56
Return on Equity (ROE)	9.58%	9.58%	-12.55%	3.08%	-3.41%	6.60%
Return on Assets (ROA)	5.98%	5.98%	1.06%	6.41%	2.46%	1.75%
Return on Capital (ROIC)	8.16%	8.16%	1.26%	6.52%	2.52%	1.81%
Return on Capital Employed (ROCE)	11.30%	11.30%	2.00%	10.50%	4.10%	2.90%
Earnings Yield	13.41%	13.87%	-19.93%	4.96%	-3.90%	4.96%
FCF Yield	45.78%	47.33%	66.47%	15.29%	-4.90%	0.16%
Buyback Yield / Dilution	2.79%	2.79%	7.83%	1.04%	2.97%	-0.51%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.